- Drug Pipelines
- January 2023
- 30 Pages
United States
From €2309EUR$2,600USD£2,017GBP
€2886EUR$3,250USD£2,521GBP
- Report
- August 2022
- 30 Pages
Global
From €2309EUR$2,600USD£2,017GBP
€2886EUR$3,250USD£2,521GBP
- Report
- November 2023
- 140 Pages
Global
From €3952EUR$4,450USD£3,452GBP
- Report
- June 2024
- 140 Pages
Europe
From €3436EUR$3,869USD£3,002GBP
- Report
- April 2024
- 140 Pages
Global
From €4395EUR$4,949USD£3,840GBP
- Report
- October 2024
- 87 Pages
North America
From €3064EUR$3,450USD£2,677GBP
From €4307EUR$4,850USD£3,763GBP
- Webinar
- February 2023
- 60 Minutes
Global
From €316EUR$355USD£276GBP
- Webinar
- September 2022
- 4 Hours
Global
From €872EUR$982USD£762GBP
- Training
- 60 Minutes
Global
From €115EUR$129USD£100GBP
-
Journal - December 2025
- 60 Pages
Global
From €377EUR$425USD£330GBP
- Report
- November 2021
- 213 Pages
Global
From €2664EUR$3,000USD£2,327GBP
Pharmacodynamic market is a segment of the healthcare services industry that focuses on the study of the effects of drugs on the body. It involves the study of the biochemical and physiological effects of drugs, as well as the mechanisms of drug action. This market includes research and development of new drugs, as well as the evaluation of existing drugs. It also includes the development of drug delivery systems, such as transdermal patches and inhalers.
The pharmacodynamic market is an important part of the healthcare services industry, as it helps to ensure the safety and efficacy of drugs. It also helps to reduce the cost of drug development and improve the quality of care.
Some companies in the pharmacodynamic market include Pfizer, Merck, GlaxoSmithKline, Novartis, and AstraZeneca. Show Less Read more
